Cargando…

189P Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer

Detalles Bibliográficos
Autores principales:	Trontzas, I.P., Vathiotis, I., Gomatou, G., Grammoustianou, M., Tsamis, I., Anagnostakis, M., Sakka, V., Poulakou, G., Syrigos, K.N., Kotteas, E.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976190/ http://dx.doi.org/10.1016/j.annonc.2022.02.114

Ejemplares similares

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
por: Trontzas, Ioannis P., et al.
Publicado: (2022)

Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence?
por: Trontzas, Ioannis P., et al.
Publicado: (2022)

Tumor Dormancy: Implications for Invasion and Metastasis
por: Gomatou, Georgia, et al.
Publicado: (2021)

Emerging therapies in thymic epithelial tumors (Review)
por: Dapergola, Athina, et al.
Publicado: (2023)

Osimertinib Resistance: Molecular Mechanisms and Emerging Treatment Options
por: Gomatou, Georgia, et al.
Publicado: (2023)

Malignant Superior Vena Cava Syndrome: State of the Art
por: Patriarcheas, Vasileios, et al.
Publicado: (2022)

Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases
por: Trontzas, Ioannis P., et al.
Publicado: (2023)

Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities
por: Tsiakos, Konstantinos, et al.
Publicado: (2022)

New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
por: Rapti, Vasiliki, et al.
Publicado: (2022)

Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

The Role of REV-ERB Receptors in Cancer Pathogenesis
por: Gomatou, Georgia, et al.
Publicado: (2023)

CD24: A Novel Target for Cancer Immunotherapy
por: Panagiotou, Emmanouil, et al.
Publicado: (2022)

Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event
por: Syrigos, Nikolaos, et al.
Publicado: (2022)

The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2021)

Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2021)

Nuclear spins of $^{186,187,188,189,189m}$Au
por: Ekström, C, et al.
Publicado: (1976)

An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review)
por: Karaviti, Eleftheria, et al.
Publicado: (2023)

High versus Standard Intensity of Thromboprophylaxis in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Kollias, Anastasios, et al.
Publicado: (2021)

Nuclear spins of $^{186}$Au, $^{187}$Au, $^{188}$Au, $^{189}$Au, $^{189}$Au.
por: Ekström, C, et al.
Publicado: (1976)

JCV seroconversion rate during the SARS COVID-19 pandemic
por: Vigiser, I., et al.
Publicado: (2022)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
por: Shahini, Endrit, et al.
Publicado: (2022)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review
por: Vathiotis, I. A., et al.
Publicado: (2021)

SARS-CoV-2 antibody seroconversion in care home
por: Shang, Joan, et al.
Publicado: (2020)

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients
por: Spencer, Elizabeth A, et al.
Publicado: (2021)

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
por: Shahini, Endrit, et al.
Publicado: (2023)

Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures
por: Gonçalves, Juliana, et al.
Publicado: (2020)

381 Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals
por: Piros, É.A., et al.
Publicado: (2022)

On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
por: Fernandes-Siqueira, Lorena O., et al.
Publicado: (2022)

Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination
por: Guven, Deniz C, et al.
Publicado: (2022)

SARS-Cov-2 Infection and Seroconversion Rates in Healthcare Providers Prior to COVID-19 Vaccine Rollout
por: Shin, Sanghyuk S., et al.
Publicado: (2023)

Seroconversion after SARS-CoV-2 mRNA booster vaccine in cancer patients
por: Patelli, Giorgio, et al.
Publicado: (2022)

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
por: Anft, Moritz, et al.
Publicado: (2023)

A serological assay to detect SARS-CoV-2 seroconversion in humans
por: Amanat, Fatima, et al.
Publicado: (2020)

Healthcare Worker Seroconversion in SARS Outbreak
por: Chow, Pierce K. H., et al.
Publicado: (2004)

Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose
por: Rossi, Andres H., et al.
Publicado: (2021)

Levels in $^{189}$Ir studied in the decay of $^{189}$Pt
por: Hedin, G, et al.
Publicado: (1972)

SARS-CoV-2 Seroconversion in Response to Infection and Vaccination: a Time Series Local Study in Brazil
por: Huergo, Luciano F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1h6qv8od7a2dit8bbqq5lug9i4